BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28062184)

  • 1. c-Jun N-terminal kinase activity is required for efficient respiratory syncytial virus production.
    Caly L; Li HM; Bogoyevitch MA; Jans DA
    Biochem Biophys Res Commun; 2017 Jan; 483(1):64-68. PubMed ID: 28062184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host Factors Modulating RSV Infection: Use of Small Interfering RNAs to Probe Functional Importance.
    Caly L; Li HM; Jans D
    Methods Mol Biol; 2016; 1442():93-117. PubMed ID: 27464690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and validation of small interfering RNA on respiratory syncytial virus M2-2 gene: A potential approach in RNA interference on viral replication.
    Chin VK; Atika Aziz NA; Hudu SA; Harmal NS; Syahrilnizam A; Jalilian FA; Zamberi S
    J Virol Methods; 2016 Oct; 236():117-125. PubMed ID: 27432115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial protein p32/HAPB1/gC1qR/C1qbp is required for efficient respiratory syncytial virus production.
    Hu M; Li HM; Bogoyevitch MA; Jans DA
    Biochem Biophys Res Commun; 2017 Aug; 489(4):460-465. PubMed ID: 28576489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
    Li J; Li M; Wang X; Sun M; Ma C; Liang W; Gao X; Wei L
    J Virol; 2020 May; 94(10):. PubMed ID: 32102886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells.
    Lingemann M; McCarty T; Liu X; Buchholz UJ; Surman S; Martin SE; Collins PL; Munir S
    PLoS Pathog; 2019 Aug; 15(8):e1007963. PubMed ID: 31381610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells.
    Khan NA; Singla M; Samal S; Lodha R; Medigeshi GR
    mSphere; 2020 May; 5(3):. PubMed ID: 32461278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grape Seed Proanthocyanidin Inhibits Mucin Synthesis and Viral Replication by Suppression of AP-1 and NF-κB via p38 MAPKs/JNK Signaling Pathways in Respiratory Syncytial Virus-Infected A549 Cells.
    Lee JW; Kim YI; Im CN; Kim SW; Kim SJ; Min S; Joo YH; Yim SV; Chung N
    J Agric Food Chem; 2017 Jun; 65(22):4472-4483. PubMed ID: 28502165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.
    Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST
    Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.
    Van der Gucht W; Leemans A; De Schryver M; Heykers A; Caljon G; Maes L; Cos P; Delputte PL
    Virol J; 2017 Aug; 14(1):157. PubMed ID: 28818113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.
    Choi EJ; Ren Y; Chen Y; Liu S; Wu W; Ren J; Wang P; Garofalo RP; Zhou J; Bao X
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel p38 mitogen activated protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and influenza A virus replication by inhibiting virus-induced p38 MAPK activation.
    Choi MS; Heo J; Yi CM; Ban J; Lee NJ; Lee NR; Kim SW; Kim NJ; Inn KS
    Biochem Biophys Res Commun; 2016 Aug; 477(3):311-6. PubMed ID: 27346133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography.
    Ke Z; Dillard RS; Chirkova T; Leon F; Stobart CC; Hampton CM; Strauss JD; Rajan D; Rostad CA; Taylor JV; Yi H; Shah R; Jin M; Hartert TV; Peebles RS; Graham BS; Moore ML; Anderson LJ; Wright ER
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30127286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective small-molecule inhibitor of c-Jun N-terminal kinase 1.
    Yao K; Cho YY; Bode AM; Vummenthala A; Park JG; Liu K; Pang YP; Dong Z
    FEBS Lett; 2009 Jul; 583(13):2208-12. PubMed ID: 19527717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNK is required for maintaining the tumor-initiating cell-like properties of acquired chemoresistant human cancer cells.
    Liu Y; Zhang X; Wang J; Yang J; Tan WF
    Acta Pharmacol Sin; 2015 Sep; 36(9):1099-106. PubMed ID: 26235742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNase L induces autophagy via c-Jun N-terminal kinase and double-stranded RNA-dependent protein kinase signaling pathways.
    Siddiqui MA; Malathi K
    J Biol Chem; 2012 Dec; 287(52):43651-64. PubMed ID: 23109342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene.
    Techaarpornkul S; Barretto N; Peeples ME
    J Virol; 2001 Aug; 75(15):6825-34. PubMed ID: 11435561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells.
    Okada M; Shibuya K; Sato A; Seino S; Watanabe E; Suzuki S; Seino M; Kitanaka C
    Oncol Rep; 2013 Oct; 30(4):1957-64. PubMed ID: 23912840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.